Shopping Cart
- Remove All
Your shopping cart is currently empty
Alflutinib (Firmonertinib) is an inhibitor of EGFR, and its targets including EGFR activating mutations and T790M, thus leading to tumor growth inhibition.

| Pack Size | Price | Availability | Quantity |
|---|---|---|---|
| 1 mg | $55 | In Stock | |
| 5 mg | $129 | In Stock | |
| 10 mg | $197 | In Stock | |
| 25 mg | $396 | In Stock | |
| 50 mg | $596 | In Stock | |
| 100 mg | $786 | In Stock | |
| 200 mg | $1,120 | In Stock | |
| 1 mL x 10 mM (in DMSO) | $163 | In Stock |
| Description | Alflutinib (Firmonertinib) is an inhibitor of EGFR, and its targets including EGFR activating mutations and T790M, thus leading to tumor growth inhibition. |
| Targets&IC50 | EGFR:, CYP3A4:0.25 μM(EC50)(Cell-free assay) |
| Synonyms | Firmonertinib, AST2818 |
| Molecular Weight | 568.59 |
| Formula | C28H31F3N8O2 |
| Cas No. | 1869057-83-9 |
| Smiles | CN1C=C(C=2C1=CC=CC2)C3=NC(NC4=C(OCC(F)(F)F)N=C(N(CCN(C)C)C)C(NC(C=C)=O)=C4)=NC=C3 |
| Relative Density. | 1.29 g/cm3 (Predicted) |
| Storage | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature. | ||||||||||||||||||||
| Solubility Information | DMSO: 10.83 mg/mL (19.05 mM), Sonication is recommended. | ||||||||||||||||||||
Solution Preparation Table | |||||||||||||||||||||
DMSO
| |||||||||||||||||||||

Copyright © 2015-2025 TargetMol Chemicals Inc. All Rights Reserved.